Michael Mitchell joined EW Healthcare in 2018 and is a Principal.
During his time at EW, Mr. Mitchell has been a key member of the deal team in a number of the firm’s growth equity investments, including EUSA Pharma, Metabolon, Cota Healthcare, Cognate BioServices, and Cardiva Medical.
Prior to joining EW, Mr. Mitchell worked at Enhanced Healthcare Partners, a lower middle-market private equity firm where he focused on the healthcare services industry. Prior to Enhanced, Mr. Mitchell worked at Cain Brothers in the firm’s investment banking practice, focusing on mergers and acquisitions in healthcare services. Mr. Mitchell began his career in investment banking at Morgan Keegan.
Mr. Mitchell received his Master of Business Administration degree from The Wharton School at the University of Pennsylvania, and a degree in Business Administration from the University of North Carolina at Chapel Hill.